MNPR — Monopar Therapeutics Inc. stock price, charts and financials

QT82Monopar Therapeutics Inc.

Monopar Therapeutics Inc. (NASDAQ: MNPR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
96.47
-6.23-6.07%
OverviewShort InterestFilings
MNPRQT82Monopar Therapeutics Inc.·NASDAQ
96.47-6.07%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 28, 20264/AStatement of changes in beneficial ownership (amended)
Aug 28, 20264/AStatement of changes in beneficial ownership (amended)
Aug 27, 20264Statement of changes in beneficial ownership
Aug 27, 20264Statement of changes in beneficial ownership
Aug 27, 20264Statement of changes in beneficial ownership
Aug 12, 20268-KCurrent report
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 202610-QQuarterly report
Jul 22, 2026S-8 POSS-8 POS
Jul 22, 2026S-8 POSS-8 POS
Jul 22, 20268-KCurrent report
Jul 22, 2026S-8 POSS-8 POS
Jul 22, 2026S-8Registration of employee benefit securities
Jul 22, 2026S-8 POSS-8 POS
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 30, 20263Initial statement of beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20268-KCurrent report
Jun 26, 20268-KCurrent report
Jun 23, 20268-KCurrent report
May 29, 20268-KCurrent report
May 19, 20268-KCurrent report
#1 / 25 of 356
Page
▼
/ 15